微创左全肺切除术的临床经验分析

The primary clinical outcome of completely thoracoscopic pneumonectomy

目的分析微创左全肺切除治疗非小细胞肺癌患者的临床资料,总结临床诊治经验。方法 2015年7月至2017年8月本院8例非小细胞肺癌患者施行微创全肺切除术,年龄52～69岁,平均(62.38±5.8)岁。手术完全在胸腔镜下进行,并规范清扫系统淋巴结。结果 8例患者手术过程均顺利,无术中大出血及输血,无中转开胸病例,术中及术后未发生严重并发症、无患者死亡。平均手术时间(76.63±14.3)min;术中出血(65±18.5)ml;清扫淋巴结数量(17.5±6.5)个;术后拔管时间(5.88±2.0)d;术后住院(8.75±1.7)d。结论非小细胞肺癌患者行微创全肺切除术的手术时间不长,出血少,术后恢复快,不增加全肺切除术围手术期风险,疗效满意,值得推广。

Objective To analysis and evaluate the treatment of the completely thoracoscopic pneumonectomy for non-small cell lung cancer. Methods From July 2015 to August 2017, 8 patients with NSCLC received completely thoracoscopic pneumonectomy. They were between age 52 and 69 years old. The average age was (62.38±5.8) years old. We used thoracoscopic equipment for pneumonectomy surgery and systematic lymph node dissection totally. Results All the patients were operated safely, without massive hemorrhage, without blood transfusion, without conversion to thoracotomy, without serious complications and death during and after operation. The blood loss was (65±18.5) ml. The mean operation time was (76.63±14.3) minutes. The mean numbers of lymph nodes dissection was (17.5±6.5). The mean time of drainage was (5.88±2.0). The mean hospitalization time was (8.75±1.7). Conclusion The completely thoracoscopic pneumonectomy is safe and effective way for the treatment of non-small cell lung cancer. The operation time is short, the bleeding is not serious, patients can get a short hositalizing time and quick postoperative recovery. There is also no increasing perioperative risk, it is worth summarizing the experience and promoting it to application.